ClinicalTrials.gg
Drug

Seltorexant clinical trials

Also written JNJ-42847922 and MIN-202;.

studies test it
32
open now
2
in phase 3
5
first study started
2014

How each study uses seltorexant is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the seltorexant studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Seltorexant
15
JNJ-42847922, 5 mg
2
JNJ-42847922, 20 mg
2
Seltorexant 40 mg
2
JNJ-42847922 20 mg
2

Development codes

JNJ-42847922
24
MIN-202;
4

Studies by the year they started

32 studies that test it; most in 2015 (7)

Studies that test seltorexant, by start year
YearStudies
20142
20157
20162
20174
20184
20191
20205
20213
20222
20241
20261

By phase

A phase 1/2 study counts in both.

Phase 1
22
Phase 2
5
Phase 3
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 32 · Other 0

Janssen Research & Development, LLC (26) · Janssen-Cilag International NV (4) · Janssen Cilag N.V./S.A. (1) · Janssen Pharmaceutical K.K. (1)

Often tested with

Tested in the same studies.

Zolpidem (1) · Diphenhydramine (1) · Ethinyl Estradiol (1) · Levonorgestrel (1) · Zopiclone (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test seltorexant, phase 3 first.

Studies

Open first, then newest update. How each study uses seltorexant is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 32

See all 32 studies that test seltorexant →

Given beside what is tested · 1 — seltorexant is usual care or a partner of the new treatment

Codes

What other systems call seltorexant · ClinicalTrials.gg INT001223

  • MeSH (NLM) C000655226seltorexantOne source NLM
  • UNII (FDA) AIS8N3O50BSELTOREXANTConfirmed FDA, NLM, Wikidata
  • Wikidata Q27273944seltorexantConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152326SeltorexantOne source FDA
  • DrugBank DB14961One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.